| Thromboembolism |
1 |
1 |
| Aspirin |
0 |
0.94 |
| Cardiac Surgery |
0 |
0.73 |
| Atrial Fibrillation |
0 |
0.67 |
| Cardiovascular Imaging |
0 |
0.4 |
| Revenue and Practice Management |
0 |
0.33 |
| Arrhythmia |
0 |
0.28 |
| Anticoagulation Therapy |
0 |
0.26 |
| Healthcare and Medical Technology |
0 |
0.17 |
| Food and Drug Administration (FDA) |
0 |
0.1 |
| Transcatheter Aortic Valve Replacement |
0 |
0.1 |
| Antithrombotics |
0 |
0.09 |
| Transesophageal Echocardiogram |
0 |
0.07 |
| Aortic Valve |
0 |
0.05 |
| Blood |
0 |
0.05 |
| Board Certification |
0 |
0.05 |
| Clinical Research |
0 |
0.05 |
| Coagulation |
0 |
0.05 |
| Echocardiography |
0 |
0.05 |
| Europe |
0 |
0.05 |
| Financial Reimbursement |
0 |
0.05 |
| Frailty |
0 |
0.05 |
| Grant |
0 |
0.05 |
| Heart |
0 |
0.05 |
| Hemorrhage |
0 |
0.05 |
| Imbalance |
0 |
0.05 |
| Lung |
0 |
0.05 |
| Medicaid |
0 |
0.05 |
| Medicare |
0 |
0.05 |
| Salary and Compensation |
0 |
0.05 |
| Texas |
0 |
0.05 |
| Valve Replacement |
0 |
0.05 |